Peraza Lisa Insider Trades

Insider Trading History

Track insider trading activity for Peraza Lisa. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Connect Biopharma Holdings
Connect Biopharma Holdings CNTB
Senior Vice President, Finance
Holding Value $104k 45,189 shares
Last Trade
Mar 16, 2026 Sale
$2.01M 745,318 shares
$2.70
$2.30
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $19.9k 41,078 shares
Last Trade
Jan 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.9k 41,078 shares
$2.09
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $27k 55,907 shares
Last Trade
Jan 13, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.63k 756 shares
$2.15
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $26.5k 54,822 shares
Last Trade
Oct 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$619 860 shares
$0.72
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $32.8k 67,941 shares
Last Trade
Jul 25, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$64.4k 42,631 shares
$1.51
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $25.7k 53,198 shares
Last Trade
Jul 25, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.3k 14,743 shares
$1.51
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$64.4k 42,631 shares
$1.51
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $72.5k 150,000 shares
Last Trade
Jul 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 150,000 shares
$1.32
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $12.2k 25,310 shares
Last Trade
Jul 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.13k 860 shares
$1.31
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $11.5k 23,685 shares
Last Trade
Apr 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.48k 860 shares
$2.88
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $20.6k 42,631 shares
Last Trade
Jan 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 42,631 shares
$3.13
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $10.7k 22,061 shares
Last Trade
Jan 13, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.21k 1,013 shares
$3.17
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $9.95k 20,589 shares
Last Trade
Oct 13, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.24k 861 shares
$3.76
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $29.4k 60,902 shares
Last Trade
Jul 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$162k 60,902 shares
$2.66
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $2.4k 4,969 shares
Last Trade
Jul 13, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.66k 552 shares
$3.01
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $9.17k 18,965 shares
Last Trade
Jul 13, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.59k 860 shares
$3.01
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $8.38k 17,340 shares
Last Trade
Apr 13, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.22k 860 shares
$6.07
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $7.87k 16,268 shares
Last Trade
Apr 13, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.35k 552 shares
$6.07
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $7.6k 15,716 shares
Last Trade
Jan 13, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$8.02k 966 shares
$8.30
$0.48
Heron Therapeutics
Heron Therapeutics HRTX
Vp, Chief Accounting Officer
Holding Value $6.86k 14,197 shares
Last Trade
Oct 13, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.02k 191 shares
$10.55
$0.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up